Effect of Gastric Bypass and Gastric Banding on Proneurotensin Levels in Morbidly Obese Patients
Open Access
- 1 September 2006
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (9) , 3544-3547
Abstract
Context: Neurotensin is produced mainly in the N cells of the ileum and has a role in appetite regulation; levels are decreased in obese subjects and increase after bariatric surgery. Mature neurotensin is very unstable, with a short half-life. Objective: The objective of this study was to compare baseline and postoperative levels of the more stable neurotensin precursor, proneurotensin/neuromedin (pro-NT/NMN), in patients after gastric banding, gastric bypass, and nonoperated controls, respectively, during long-term follow-up. Design and Setting: This was a prospective observational study in a university hospital. Participants and Main Outcome Measures: Overnight fasting plasma pro-NT/NMN concentrations were measured with a new sandwich immunoassay in morbidly obese subjects at baseline and 6, 12, and 24 months after gastric banding (n = 8), Roux-en-Y gastric bypass (n = 5), and in nonoperated controls (n = 7). Results: After gastric bypass and banding, body weight decreased by (mean ± sd) 29.5 ± 5.5 and 22.8 ± 5.9 kg, respectively. The decrease after 3 and 6 months was more pronounced after gastric bypass compared with gastric banding (P < 0.05). Plasma pro-NT/NMN levels in patients after gastric bypass increased from 246.3 ± 174.3 pmol/liter on admission to 748.3 ± 429.6 pmol/liter after 24 months (P < 0.01). In contrast, in patients with gastric banding, pro-NT/NMN concentrations remained stable (207.3 ± 60.5 pmol/liter at admission, 226.6 ± 116.8 pmol/liter after 24 months). Neither body weight nor plasma pro-NT/NMN levels changed in nonoperated controls. Conclusion: Plasma pro-NT/NMN levels show a more pronounced increase after gastric bypass compared with gastric banding, suggesting that specific bariatric surgical procedures result in distinct alterations of gastrointestinal hormone metabolism. The more stable precursor pro-NT/NMN provides a new tool to quantify neurotensin levels in clinical practice.Keywords
This publication has 20 references indexed in Scilit:
- Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric SurgeryNew England Journal of Medicine, 2004
- Effects of Adjustable Gastric Banding on Altered Gut Neuropeptide Levels in Morbidly Obese PatientsObesity Surgery, 2001
- Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patternsThe American Journal of Clinical Nutrition, 1997
- Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin,in vivo, in the vascularly perfused dog ileumBritish Journal of Pharmacology, 1994
- Central neurotensin inhibits gastric acid secretion: An adrenergic mechanism in ratsGastroenterology, 1989
- Neuromedin N: High affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidasesEuropean Journal of Pharmacology, 1986
- Central nervous system neurotensin and feedingPhysiology & Behavior, 1986
- Release and degradation of neurotensin during perfusion of rat small intestine with lipidRegulatory Peptides, 1985
- Role of nutrients in the gastrointestinal release of immunoreactive neurotensinPeptides, 1981
- Immunohistochemical localization of neurotensin in endocrine cells of the gutCell and tissue research, 1977